BACKGROUND & AIMS: The glucocorticoid-induced tumor necrosis factor receptor family-related protein (GITR; also called TNFRSF18 or CD357) regulates the T cell-mediated immune response and is present on surfaces of regulatory T (Treg) cells and activated CD4(+) T cells. We investigated the roles of GITR in the development of colitis in mice. METHODS: Chronic enterocolitis was induced by the transfer of wild-type or GITR(-/-) CD4(+) T cells to GITR(-/-) × Rag(-/-) or Rag(-/-) mice. We determined the severity of colitis by using the disease activity index; measured levels of inflammatory cytokines, T cells, and dendritic cells; and performed histologic analysis of colon samples. RESULTS: Transfer of nonfractionated CD4(+) cells from wild-type or GITR(-/-) donors induced colitis in GITR(-/-) × Rag(-/-) but not in Rag(-/-) mice. Among mice with transfer-induced colitis, the percentage of Treg and T-helper (Th) 17 cells was reduced but that of Th1 cells increased. Treg cells failed to prevent colitis in GITR(-/-) × Rag(-/-) recipients; this was not the result of aberrant function of GITR(-/-) Treg or T effector cells but resulted from an imbalance between the numbers of tolerogenic CD103(+) and PDCA1(+) plasmacytoid dendritic cells in GITR(-/-) mice. This imbalance impaired Treg cell development and expanded the Th1 population in GITR(-/-) × Rag(-/-) mice following transfer of nonfractionated CD4(+) cells. CONCLUSIONS: GITR is not required on the surface of Treg and T effector cells to induce colitis in mice; interactions between GITR and its ligand are not required for induction of colitis. GITR instead appears to control dendritic cell and monocyte development; in its absence, mice develop aggravated chronic enterocolitis via an imbalance of colitogenic Th1 cells and Treg cells. Copyright Â
BACKGROUND & AIMS: The glucocorticoid-induced tumor necrosis factor receptor family-related protein (GITR; also called TNFRSF18 or CD357) regulates the T cell-mediated immune response and is present on surfaces of regulatory T (Treg) cells and activated CD4(+) T cells. We investigated the roles of GITR in the development of colitis in mice. METHODS:Chronic enterocolitis was induced by the transfer of wild-type or GITR(-/-) CD4(+) T cells to GITR(-/-) × Rag(-/-) or Rag(-/-) mice. We determined the severity of colitis by using the disease activity index; measured levels of inflammatory cytokines, T cells, and dendritic cells; and performed histologic analysis of colon samples. RESULTS: Transfer of nonfractionated CD4(+) cells from wild-type or GITR(-/-) donors induced colitis in GITR(-/-) × Rag(-/-) but not in Rag(-/-) mice. Among mice with transfer-induced colitis, the percentage of Treg and T-helper (Th) 17 cells was reduced but that of Th1 cells increased. Treg cells failed to prevent colitis in GITR(-/-) × Rag(-/-) recipients; this was not the result of aberrant function of GITR(-/-) Treg or T effector cells but resulted from an imbalance between the numbers of tolerogenic CD103(+) and PDCA1(+) plasmacytoid dendritic cells in GITR(-/-) mice. This imbalance impaired Treg cell development and expanded the Th1 population in GITR(-/-) × Rag(-/-) mice following transfer of nonfractionated CD4(+) cells. CONCLUSIONS:GITR is not required on the surface of Treg and T effector cells to induce colitis in mice; interactions between GITR and its ligand are not required for induction of colitis. GITR instead appears to control dendritic cell and monocyte development; in its absence, mice develop aggravated chronic enterocolitis via an imbalance of colitogenic Th1 cells and Treg cells. Copyright Â
Authors: L Santucci; M Agostini; S Bruscoli; A Mencarelli; S Ronchetti; E Ayroldi; A Morelli; M Baldoni; C Riccardi Journal: Gut Date: 2006-06-08 Impact factor: 23.059
Authors: Ronald W van Olffen; Nathalie Koning; Klaas P J M van Gisbergen; Felix M Wensveen; Robert M Hoek; Louis Boon; Jörg Hamann; Rene A W van Lier; Martijn A Nolte Journal: J Immunol Date: 2009-06-15 Impact factor: 5.422
Authors: Anna Vecchiarelli; Eva Pericolini; Elena Gabrielli; Massimiliano Agostini; Francesco Bistoni; Giuseppe Nocentini; Elio Cenci; Carlo Riccardi Journal: Cell Immunol Date: 2009-03-09 Impact factor: 4.868
Authors: Ursula Grohmann; Claudia Volpi; Francesca Fallarino; Silvia Bozza; Roberta Bianchi; Carmine Vacca; Ciriana Orabona; Maria L Belladonna; Emira Ayroldi; Giuseppe Nocentini; Louis Boon; Francesco Bistoni; Maria C Fioretti; Luigina Romani; Carlo Riccardi; Paolo Puccetti Journal: Nat Med Date: 2007-04-08 Impact factor: 53.440
Authors: Janine L Coombes; Karima R R Siddiqui; Carolina V Arancibia-Cárcamo; Jason Hall; Cheng-Ming Sun; Yasmine Belkaid; Fiona Powrie Journal: J Exp Med Date: 2007-07-09 Impact factor: 14.307
Authors: Marcos W Steinberg; Olga Turovskaya; Raziya B Shaikh; Gisen Kim; Declan F McCole; Klaus Pfeffer; Kenneth M Murphy; Carl F Ware; Mitchell Kronenberg Journal: J Exp Med Date: 2008-06-02 Impact factor: 14.307
Authors: Elin Jaensson; Heli Uronen-Hansson; Oliver Pabst; Bertus Eksteen; Jiong Tian; Janine L Coombes; Pia-Lena Berg; Thomas Davidsson; Fiona Powrie; Bengt Johansson-Lindbom; William W Agace Journal: J Exp Med Date: 2008-08-18 Impact factor: 14.307
Authors: Ashley T Martino; Etiena Basner-Tschakarjan; David M Markusic; Jonathan D Finn; Christian Hinderer; Shangzhen Zhou; David A Ostrov; Arun Srivastava; Hildegund C J Ertl; Cox Terhorst; Katherine A High; Federico Mingozzi; Roland W Herzog Journal: Blood Date: 2013-01-16 Impact factor: 22.113
Authors: Gongxian Liao; Boaz van Driel; Erica Magelky; Michael S O'Keeffe; Rene de Waal Malefyt; Pablo Engel; Roland W Herzog; Emiko Mizoguchi; Atul K Bhan; Cox Terhorst Journal: FASEB J Date: 2013-10-09 Impact factor: 5.191
Authors: Xiaomei Wang; Alexandra Sherman; Gongxian Liao; Kam W Leong; Henry Daniell; Cox Terhorst; Roland W Herzog Journal: Adv Drug Deliv Rev Date: 2012-11-02 Impact factor: 15.470
Authors: Brett Palaschak; Damien Marsic; Roland W Herzog; Sergei Zolotukhin; David M Markusic Journal: Mol Ther Methods Clin Dev Date: 2017-04-19 Impact factor: 6.698
Authors: Gongxian Liao; Michael S O'Keeffe; Guoxing Wang; Boaz van Driel; Rene de Waal Malefyt; Hans-Christian Reinecker; Roland W Herzog; Cox Terhorst Journal: Front Immunol Date: 2014-02-03 Impact factor: 7.561